← Open Payments lookup

ERIN VILLELA: Open Payments

NPI 1942434360 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,237 in 95 payments from 9 companies in 2025. Trend: 2023 $1,081 · 2024 $1,173 · 2025 $1,237

Food & beverage: $1,230Education: $7
CompanyPaymentsAmount
Novo Nordisk Inc22$281
Amgen Inc.22$267
Lilly USA, LLC16$165
Takeda Pharmaceuticals U.S.A., Inc.12$164
ABBVIE INC.12$163
GlaxoSmithKline, LLC.3$68
AstraZeneca Pharmaceuticals LP3$57
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$44
Bayer Healthcare Pharmaceuticals Inc.2$28

Products named: OTEZLA, TRINTELLIX, MOUNJARO, QULIPTA, Ozempic, TRELEGY ELLIPTA, Rybelsus, XIFAXAN.

Industry payments across TX — which companies pay providers there.